Colin Cormack Seaton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Colin Cormack Seaton has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Anant Paradkar
University of Bradford
3 shared publications - Mingzhong Li
School of Pharmacy, De Montfort University, Leicester LE1 9BH, UK
3 shared publications Richard D. Bowen
School of Chemistry and Biosciences, University of Bradford, Richmond Road, Bradford BD7 1DP, UK
3 shared publicationsRichard Telford
School of Chemistry and Biosciences, University of Bradford, Richmond Road, Bradford BD7 1DP, U.K.
3 shared publications- Thomas Swift
School of Chemistry and Biosciences, University of Bradford, Bradford, BD7 1DP, UK
3 shared publications Adrian L. Kelly
Centre for Pharmaceutical Engineering Science, Faculty of Engineering and Informatics, University of Bradford, Great Horton Road, Bradford, BD7 1DP, United Kingdom
2 shared publications
Latest Publications
- Open Access
- 16 May 2025
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 25 (11) , 3928-3937
Predictability of Isostructurality within Monosubstituted Cinnamide Crystals
- 16 May 2025
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 25 (11) , 3928-3937
Open AccessPredictability of Isostructurality within Monosubstituted Cinnamide Crystals
- Open Access
- 21 March 2025
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 23 (23) , 5590-5599
Solvatomorphism of a 2,6-pyridyldicarboxamide-based foldamer
A detailed solvatomorphism study conducted on a diamine-terminated 2,6-pyridyldicarboxamide-based foldamer 1 is reported. This investigation establishes the influence of a diverse range of polar and non-polar solvents including chloroform (1A), a trifluorotoluene/dichloromethane mixture (1A), dimethylformamide/diethyl ether (1B), tetrahydrofuran (1·THF), butanone (1·butanone), dichloromethane (1·DCM), a methanol/dichloromethane mixture (1·MeOH) and dimethylsulfoxide (1·DMSO) on the solid-state conformation and crystal packing behaviour of this supramolecular scaffold. Single-crystal X-ray diffraction analysis of the seven solvatomorphs of the studied foldamer (1A, 1B, 1·DCM, 1·THF, 1·butanone, 1·MeOH and 1·DMSO) identified that 1·DCM, 1·THF, 1·butanone, 1·MeOH and 1·DMSO form supramolecular aggregates (e.g., channels/cavities) which incorporate solvent molecules within the voids of the system, leading them to adopt channels of differing dimensions between 3.5 and 9.0 Å. Solid-state analysis identified that a diverse array of intermolecular non-covalent interactions form between the foldamer and the solvent molecule, including N–H⋯O, N–H⋯Cl, O–H⋯O, N–H⋯Cl and C–H⋯O hydrogen-bonding interactions, stabilising the formation of these solvent-mediated channel aggregates within the different solvatomorphs of the studied foldamer. We envisage that these solvatomorphism studies will facilitate the future design of foldamers, particularly given the emerging solid-state applications of foldamers which could hold relevance in the field of crystal engineering or for the uptake of small molecules for long-term use in energy storage and materials chemistry.
- 21 March 2025
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 23 (23) , 5590-5599
Open AccessSolvatomorphism of a 2,6-pyridyldicarboxamide-based foldamer
A detailed solvatomorphism study conducted on a diamine-terminated 2,6-pyridyldicarboxamide-based foldamer 1 is reported. This investigation establishes the influence of a diverse range of polar and non-polar solvents including chloroform (1A), a trifluorotoluene/dichloromethane mixture (1A), dimethylformamide/diethyl ether (1B), tetrahydrofuran (1·THF), butanone (1·butanone), dichloromethane (1·DCM), a methanol/dichloromethane mixture (1·MeOH) and dimethylsulfoxide (1·DMSO) on the solid-state conformation and crystal packing behaviour of this supramolecular scaffold. Single-crystal X-ray diffraction analysis of the seven solvatomorphs of the studied foldamer (1A, 1B, 1·DCM, 1·THF, 1·butanone, 1·MeOH and 1·DMSO) identified that 1·DCM, 1·THF, 1·butanone, 1·MeOH and 1·DMSO form supramolecular aggregates (e.g., channels/cavities) which incorporate solvent molecules within the voids of the system, leading them to adopt channels of differing dimensions between 3.5 and 9.0 Å. Solid-state analysis identified that a diverse array of intermolecular non-covalent interactions form between the foldamer and the solvent molecule, including N–H⋯O, N–H⋯Cl, O–H⋯O, N–H⋯Cl and C–H⋯O hydrogen-bonding interactions, stabilising the formation of these solvent-mediated channel aggregates within the different solvatomorphs of the studied foldamer. We envisage that these solvatomorphism studies will facilitate the future design of foldamers, particularly given the emerging solid-state applications of foldamers which could hold relevance in the field of crystal engineering or for the uptake of small molecules for long-term use in energy storage and materials chemistry.
- 22 January 2025
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 25 (3) , 540-553
Multicomponent Crystal Forms of Albendazole for Bioavailability Improvement
- 22 January 2025
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 25 (3) , 540-553
Multicomponent Crystal Forms of Albendazole for Bioavailability Improvement
- Open Access
- 18 November 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (11) , 1467
Formulation, Characterisation, and Biocompatibility Assessment of Rifampicin-Loaded Poly(d,l-lactide-co-glycolide) Composites for Local Treatment of Orthopaedic and Wound Infections
Background/Objectives: The escalating challenge of antimicrobial resistance (AMR) necessitates the development of targeted antibiotic delivery platforms, minimising systemic administration. Polymer-based drug delivery emerges as a promising solution, ensuring sustained release and prolonged efficacy of bioactive compounds, ensuring long-term efficacy. Methods: This study focuses on encapsulating rifampicin (RIF), a key antibiotic for orthopaedic and wound-related infections, within Poly(d,l-lactide-co-glycolide) (PLGA), a biodegradable polymer, through solvent casting, to formulate a PLGA-RIF composite membrane. Comprehensive characterisation, employing Fourier-transformed infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), thermal analysis and X-ray Diffraction (XRD), confirmed the integrity of both the starting and produced materials. UV-Vis spectroscopy revealed a controlled drug release profile over 21 days in various media, with the chosen media influencing the drug release, notably the tryptic soya broth (TSB) caused the highest release. The quantitative assessment of the antimicrobial efficacy of the developed PLGA-RIF composite was conducted by measuring the size of the inhibition zones against both Gram-negative and Gram-positive bacteria. Results: The results confirmed the composite’s potential as a robust antibacterial biomaterial, demonstrating a rapid and effective antibacterial response. Cytocompatibility tests incorporated human fibroblast and osteoblast-like cell lines and demonstrated that the RIF:PLGA (1:8) formulation maintained eukaryotic cell viability, indicating the composite’s potential for targeted medical applications in combating bacterial infections with minimal systemic impact. Conclusions: This study presents the significance of investigating drug release within appropriate and relevant physiological media. A key novelty of this work therefore lies in the exploration of drug release dynamics across different media, allowing for a comprehensive understanding of how varying physiological conditions may influence drug release and its effect on biological responses.
- 18 November 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (11) , 1467
Open AccessFormulation, Characterisation, and Biocompatibility Assessment of Rifampicin-Loaded Poly(d,l-lactide-co-glycolide) Composites for Local Treatment of Orthopaedic and Wound Infections
Background/Objectives: The escalating challenge of antimicrobial resistance (AMR) necessitates the development of targeted antibiotic delivery platforms, minimising systemic administration. Polymer-based drug delivery emerges as a promising solution, ensuring sustained release and prolonged efficacy of bioactive compounds, ensuring long-term efficacy. Methods: This study focuses on encapsulating rifampicin (RIF), a key antibiotic for orthopaedic and wound-related infections, within Poly(d,l-lactide-co-glycolide) (PLGA), a biodegradable polymer, through solvent casting, to formulate a PLGA-RIF composite membrane. Comprehensive characterisation, employing Fourier-transformed infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), thermal analysis and X-ray Diffraction (XRD), confirmed the integrity of both the starting and produced materials. UV-Vis spectroscopy revealed a controlled drug release profile over 21 days in various media, with the chosen media influencing the drug release, notably the tryptic soya broth (TSB) caused the highest release. The quantitative assessment of the antimicrobial efficacy of the developed PLGA-RIF composite was conducted by measuring the size of the inhibition zones against both Gram-negative and Gram-positive bacteria. Results: The results confirmed the composite’s potential as a robust antibacterial biomaterial, demonstrating a rapid and effective antibacterial response. Cytocompatibility tests incorporated human fibroblast and osteoblast-like cell lines and demonstrated that the RIF:PLGA (1:8) formulation maintained eukaryotic cell viability, indicating the composite’s potential for targeted medical applications in combating bacterial infections with minimal systemic impact. Conclusions: This study presents the significance of investigating drug release within appropriate and relevant physiological media. A key novelty of this work therefore lies in the exploration of drug release dynamics across different media, allowing for a comprehensive understanding of how varying physiological conditions may influence drug release and its effect on biological responses.
- Open Access
- 19 January 2024
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 24 (3) , 1124-1135
Crystal or Glass? Chemical and Crystallographic Factors in the Amorphization of Molecular Materials
- 19 January 2024
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 24 (3) , 1124-1135
Open AccessCrystal or Glass? Chemical and Crystallographic Factors in the Amorphization of Molecular Materials
- 12 April 2023
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 23 (5) , 3480-3495
Apigenin Cocrystals: From Computational Prescreening to Physicochemical Property Characterization
- 12 April 2023
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 23 (5) , 3480-3495
Apigenin Cocrystals: From Computational Prescreening to Physicochemical Property Characterization
- Open Access
- 17 February 2023
- Published by Wiley in Coloration Technology
- Vol. 139 (5) , 610-620
Investigation into the development of novel lanthanide‐based luminescent colorants for application to textiles and paper materials
This article describes the synthesis and application of lanthanide‐based luminophores for visualisation under short wavelength ultraviolet (UV) activation (typically 254 nm). Luminophores are chemical compounds which re‐emit light of longer wavelength than typical fluorescence and phosphorescence, following photoexcitation, because of efficient energy transfer from the ligands to the lanthanide ion emission levels. The luminophores described in this article are all derived from europium and terbium metal complexes and cover the complete colour gamut. Selection of appropriate ligands allows for water solubility or water insolubility (if required pigment or disperse “dye” applications). Similar to dyeing or printing processes, the anionic complexes can be applied to polyamide fibres or to cellulosic fibres, whereas dispersions of the non‐ionic complexes are suitable for polyester or cellulose acetate fibre application. The water‐soluble derivatives are also suitable for ink‐jet printing and the water‐insoluble derivatives are suitable for lithographic or intaglio paper printing. The novel complexes are excited by radiation below 300 nm and thus cannot be activated by sunlight (the earth's atmosphere prevents light below about 300 nm reaching the surface). Accordingly, the photo‐stability of the dyed materials and prints obtained is excellent. These materials could be used in security marking applications, for example bank‐notes and passports, where they could replace the current fluorophores that are rendered visible under near UV light (typically 365 nm) illumination but exhibit relatively poor photo‐stability. The development of an RGB (red, green and blue) colour palette for inkjet printing based on these innovative luminophores will significantly support the design of digitally printed security features.
- 17 February 2023
- Published by Wiley in Coloration Technology
- Vol. 139 (5) , 610-620
Open AccessInvestigation into the development of novel lanthanide‐based luminescent colorants for application to textiles and paper materials
This article describes the synthesis and application of lanthanide‐based luminophores for visualisation under short wavelength ultraviolet (UV) activation (typically 254 nm). Luminophores are chemical compounds which re‐emit light of longer wavelength than typical fluorescence and phosphorescence, following photoexcitation, because of efficient energy transfer from the ligands to the lanthanide ion emission levels. The luminophores described in this article are all derived from europium and terbium metal complexes and cover the complete colour gamut. Selection of appropriate ligands allows for water solubility or water insolubility (if required pigment or disperse “dye” applications). Similar to dyeing or printing processes, the anionic complexes can be applied to polyamide fibres or to cellulosic fibres, whereas dispersions of the non‐ionic complexes are suitable for polyester or cellulose acetate fibre application. The water‐soluble derivatives are also suitable for ink‐jet printing and the water‐insoluble derivatives are suitable for lithographic or intaglio paper printing. The novel complexes are excited by radiation below 300 nm and thus cannot be activated by sunlight (the earth's atmosphere prevents light below about 300 nm reaching the surface). Accordingly, the photo‐stability of the dyed materials and prints obtained is excellent. These materials could be used in security marking applications, for example bank‐notes and passports, where they could replace the current fluorophores that are rendered visible under near UV light (typically 365 nm) illumination but exhibit relatively poor photo‐stability. The development of an RGB (red, green and blue) colour palette for inkjet printing based on these innovative luminophores will significantly support the design of digitally printed security features.
- Open Access
- 14 September 2022
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 22 (10) , 5845-5851
Interfacial Cocrystallization Using Oily Phase via Liquid–Liquid Phase Separation
- 14 September 2022
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 22 (10) , 5845-5851
Open AccessInterfacial Cocrystallization Using Oily Phase via Liquid–Liquid Phase Separation
- Open Access
- 3 February 2022
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 22 (3) , 1724-1730
Construction of Ternary Phase Diagrams: Application of Quantitative NMR
- 3 February 2022
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 22 (3) , 1724-1730
Open AccessConstruction of Ternary Phase Diagrams: Application of Quantitative NMR
- 23 December 2021
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 24 (5) , 1056-1067
Artemisinin–acetylenedicarboxylic acid cocrystal: screening, structure determination, and physicochemical property characterisation
Artemisinin is used to treat multi-drug resistant strains of malaria and is also in the early stages of development as an anti-cancer drug. However, the usage of artemisinin is limited due to its low aqueous solubility. Herein a large scale cocrystal screening of artemisinin was conducted using both computational and experimental approaches, leading to a new 2 : 1 artemisinin and acetylenedicarboxylic acid (ART2–ACA) cocrystal. ART2–ACA crystallises in the P212121 space group of the orthorhombic system with cell parameters a = 10.5089 Å, b = 24.083 Å, and c = 6.4952 Å. The asymmetric unit of the cocrystal contains two ART molecules and a single ACA molecule, assembled into discrete trimeric units held together by two supramolecular heterosynthons. It was shown that ART2–ACA cocrystals have higher solubility and a faster dissolution rate compared to the parent drug artemisinin.
- 23 December 2021
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 24 (5) , 1056-1067
Artemisinin–acetylenedicarboxylic acid cocrystal: screening, structure determination, and physicochemical property characterisation
Artemisinin is used to treat multi-drug resistant strains of malaria and is also in the early stages of development as an anti-cancer drug. However, the usage of artemisinin is limited due to its low aqueous solubility. Herein a large scale cocrystal screening of artemisinin was conducted using both computational and experimental approaches, leading to a new 2 : 1 artemisinin and acetylenedicarboxylic acid (ART2–ACA) cocrystal. ART2–ACA crystallises in the P212121 space group of the orthorhombic system with cell parameters a = 10.5089 Å, b = 24.083 Å, and c = 6.4952 Å. The asymmetric unit of the cocrystal contains two ART molecules and a single ACA molecule, assembled into discrete trimeric units held together by two supramolecular heterosynthons. It was shown that ART2–ACA cocrystals have higher solubility and a faster dissolution rate compared to the parent drug artemisinin.